Skip to content

Dossier · BAK · Dormant

BAK · Braskem S.A. · Stock research

Last analysed ·

Current thesis

Distress jumped from the Idesa JV to the parent: ~2026-06-29 Braskem S.A. won a 60-day creditor standstill, Fitch cut to C and S&P to D (default), and JPMorgan capitulated to Neutral (2026-06-30) as creditors rejected management's plan and demanded shareholder burden-sharing. ADR ~$2.30 at 52-week lows with equity-impairment risk in an extrajudicial restructuring. No momentum leg a distressed avoid.

Invalidation trigger

A weekly close below $2.00 confirms the market pricing equity impairment in the extrajudicial restructuring; further confirmed by a shift to full judicial reorganization or DIP terms subordinating the common. A bullish turn instead needs a higher low and reclaim of ~$3 on volume alongside a creditor deal that spares equity.

Thesis status

Open commitment catalyst 41d agoscored if the trigger above fires How this is scored →

Latest analysis and events for BAK —

As of 2026-07-11, orbyd's latest analysis for Braskem S.A. (BAK): Distress jumped from the Idesa JV to the parent: ~2026-06-29 Braskem S.A. won a 60-day creditor standstill, Fitch cut to C and S&P to D (default), and JPMorgan capitulated to Neutral (2026-06-30) as creditors rejected management's plan and demanded shareholder burden-sharing. ADR ~$2.30 at 52-week lows with equity-impairment risk in an extrajudicial restructuring. No momentum leg a distressed avoid.

Invalidation trigger: A weekly close below $2.00 confirms the market pricing equity impairment in the extrajudicial restructuring; further confirmed by a shift to full judicial reorganization or DIP terms subordinating the common. A bullish turn instead needs a higher low and reclaim of ~$3 on volume alongside a creditor deal that spares equity.

Most recent dated event on file: — catalyst 41d ago.

Current Thesis

The distress that defined this name for a year has jumped one level up the capital structure from the Braskem Idesa Mexican JV to the parent itself. On roughly 2026-06-29 Braskem S.A. secured a Brazilian tutela cautelar (precautionary court order) that pauses financial-creditor collection for 60 days while it seeks backing for an out-of-court (extrajudicial) restructuring. Fitch cut the global-scale rating to C and S&P to D (default territory) the same window; JPMorgan, the last standing bull, capitulated to Neutral on 2026-06-30 and slashed its target to R$7.50 from R$15. The trigger for the equity read: creditors rejected management's initial restructuring proposal and are demanding "greater shareholder burden-sharing," which puts dilution or impairment of the common squarely on the table. The ADR has responded by collapsing to ~$2.30 (2026-07-11), sitting on its 52-week low of $2.25 after a ~33% drawdown from ~$3.44 in mid-June. There is no momentum leg, no peer cluster, and the setup is a distressed special situation with equity-wipeout tail risk not a narrative-momentum trade. Stand aside.

Bullish and bearish views on Braskem S.A.

The model's bull view on Braskem S.A. (BAK), in brief: 60-day standstill buys negotiating time (~2026-06-29). The bear view: Parent is now in default per S&P (D) and near-default per Fitch (C), ~2026-06-29. Both cases follow in full.

Bull Case

  • 60-day standstill buys negotiating time (~2026-06-29). The tutela cautelar freezes financial-creditor collection through roughly late August, and management flagged that commercial obligations continue normally. An out-of-court recuperação extrajudicial is a lighter-touch path than full judicial reorganization if the company secures holders of one-third of debt.
  • Q1 2026 spread inflection (reported 2026-05-13). Recurring EBITDA of US$192M (R$1,006M) rose +76% QoQ on firmer polyolefin spreads plus a ~US$32M REIQ tax benefit; Middle East logistics disruptions tightened global supply, supporting a cyclical-bottom read for petrochemical margins into 2027.
  • Co-control owners with restructuring incentive. IG4 Capital (turnaround PE) controls ~50.1% of voting capital via the Shine I fund and Petrobras holds ~47% as co-controller (board seated 2026-06-08); both have reason to protect equity value in the negotiation rather than accept a wipeout.
  • Deep convexity if equity is spared. At ~$2.30 against a Street average target of $3.00, any creditor deal that extends maturities without material dilution moves the option-like common in large percentage terms.

Bear Case

  • Parent is now in default per S&P (D) and near-default per Fitch (C), ~2026-06-29. The distress is no longer ring-fenced in a subsidiary; it is the consolidated entity, with ratings at the bottom of the scale.
  • Liquidity cliff vs the debt wall. July debt service totals ~US$521–549M and Q3 2026 ~US$878M against an estimated ~US$800M cash as of June. Acceleration / early-payment clauses put an estimated ~R$54B (~US$10.4B) of debt at risk the reason the standstill exists.
  • Creditors want equity to pay (2026-06-30). JPMorgan's downgrade note states creditors rejected management's initial plan and called for greater shareholder burden-sharing, and that the range of shareholder outcomes is "less favorable than previously anticipated" direct dilution/impairment risk.
  • a parallel drain on parent attention and potential guarantee exposure.
  • Structure is broken, not basing. ~16.81x parent net leverage (Q1), a Moderate Sell consensus, and price making fresh 52-week lows with no higher low. The prior $3.00 line has already been lost.

Setup & Price Structure

The ADR trades ~$2.30 on 2026-07-11 (-3.56% on the day, -8.24% on the week), pinned to the 52-week low of $2.25 within a 52-week range of $2.25–5.40. The tape sliced through the old $3.00 shelf that framed the prior bear line and has printed a straight ~33% decline from ~$3.44 in mid-June with no reclaim attempt. Every moving average sits above spot; there is no volume base, no higher low, and no peer confirmation from Brazilian petrochemical or EM-industrial names. Sell-side has converged bearish: JPMorgan Neutral (R$7.50) as of 2026-06-30, consensus Moderate Sell with an average target near $3.00. This is a falling knife around a binary restructuring, and chasing the equity into a creditor negotiation that explicitly contemplates shareholder burden-sharing is the definition of catching value-trap risk without a catalyst edge.

Catalyst Calendar (next 30 days)

  • ~mid-to-late July 2026 (est.): July debt service of ~US$549M (principal + interest) falls due; the standstill pauses financial creditors, but liquidity against ~US$800M cash is the live test.
  • Imminent (reported "as early as next week" early July, Estadão/Reuters): Braskem Idesa US Chapter 11 filing with a ~US$250M DIP facility.
  • Rolling through ~2026-08-28 (est., 60 days from the ~06-29 order): recuperação extrajudicial negotiation window company needs holders of ~one-third of debt to support a filing; any headline on creditor acceptance or a revised plan re-prices the equity in either direction.
  • ~mid-August 2026 (est.): Q2 2026 earnings; no earnings binary inside the next 30 days.

What Would Change Our Mind

A bullish turn requires a creditor agreement that extends maturities without material equity dilution, paired with a higher low and a reclaim of ~$3 on rising volume evidence the market is pricing survival of the common rather than impairment. Petrochemical spreads re-accelerating above the Q1 +76% QoQ EBITDA rebound, and removal of the ~R$54B acceleration overhang, would corroborate. Confirmation of the bear runs the other way: an extrajudicial plan structured on shareholder contribution, a shift from precautionary order to full judicial reorganization, or DIP/restructuring terms that subordinate the common. Until a base forms, this is a headline-driven event, not a setup chase only a confirmed constructive outcome, never pre-position, never average down.

Correlation Notes

BAK is an ADR of BRKM5 (B3), so it carries USD/BRL translation risk on top of company beta. Fundamental drivers are petrochemical spreads (ethylene, polyethylene, polypropylene, PVC) and naphtha/oil feedstock costs, with Petrobras a 47% co-controller and feedstock counterparty. Correlation to US large-cap momentum and AI-adjacent themes is negligible; the name trades on idiosyncratic distressed-credit and EM-Brazil risk. In a broad risk-off or EM-credit-widening tape, distressed single names like this de-rate faster than the index, and the restructuring outcome not market beta dominates the return distribution from here.

Correlation Notes (cross-check)

Peer read: no Brazilian petrochemical or EM-industrial cluster is breaking out to confirm any bounce, so a rally would be single-name mean-reversion rather than thematic strength.

Notes

  • THEME MIS-TAG: prior pipeline bucketed BAK into 'commodity-materials-rare-earths' WRONG. Braskem is a Brazilian petrochemical (PE/PP/PVC) producer. Re-tag to petrochem/distressed-credit/EM-Brazil.
  • No price context supplied this run verify live ADR price before any action; numbers above (~$3–5) are estimates.
  • Not a narrative-momentum setup: no accelerating theme, no peer cluster, debt distress at Braskem Idesa. Default pass / keep DORMANT.
  • Only tradable angle is an event-driven binary (Novonor controlling-stake sale or Braskem Idesa restructuring close) chase on confirmed headline, never pre-position, never average down.
  • Q1 2026 reported 2026-05-13 (call 2026-05-15); next earnings ~August. No earnings binary inside 30d.
  • Binary RESOLVED: Novonor stake sale closed June 2026 Shine I FIP (IG4 Capital) 50.11% voting / 34.32% total; Petrobras + FIP co-control via consensus/veto. Governance EGM 2026-06-08. Reaction was sell-the-news (ADR $3.48, -7.45% on 2026-06-05).
  • THEME MIS-TAG history: prior pipeline bucketed BAK as 'commodity-materials-rare-earths' WRONG. Braskem = Brazilian petrochemical (PE/PP/PVC). Keep petrochem/distressed-credit/EM-Brazil tags.
  • Balance sheet is the gating risk: adj net debt $8.483B, Net Debt/Recurring EBITDA 16.81x, cash $1.1B, Q1 net loss R$9.9B, ratings CC/CCC- neg (Q1 2026, reported 2026-05-13). Recurring EBITDA $192M, +76% QoQ.
  • Live binary now = Braskem Idesa (75% JV) Chapter 11 / ~$250M DIP loan; missed 2029/2032 note interest; 2026-06-04 Bloomberg restructuring-terms headline. Undated chase on confirmed outcome, never pre-position.
  • Sell-side split: JPM Overweight PT $5.50 ADR / R$15 (2026-05-12, from Neutral); BofA Underperform R$7.50 local; consensus Reduce/Hold ~$3.87.
  • Not a momentum/cluster setup. Default pass / DORMANT; any entry = confirmed base + reclaim ~$4 on volume, never average down.
  • Next earnings Q2 2026 ~August (est.); no earnings binary inside 30d.
  • THEME TAG: Braskem = Brazilian petrochemical (PE/PP/PVC) producer. Keep petrochem/distressed-credit/EM-Brazil tags; prior pipeline mis-bucketed as 'commodity-materials-rare-earths' wrong.
  • Control change CLOSED: IG4 Capital co-control finalized 2026-06-04 (Shine I FIP ~50.1% voting), Petrobras 47%, Novonor ~4% non-voting. New board seated 2026-06-08, chair = Petrobras CEO Magda Chambriard. Digital EGM postponed pending judicial authorizations but hand-off done.
  • Live binary = Braskem Idesa (75% JV) restructuring: ~40.31x leverage (March), missed interest on 2029 notes (2025-11-18) and 2032 notes (2026-02-20), ~US$2B bonds, assessing US Chapter 11; DIP may involve the parent holding; Equity Support Agreement guarantees 50% of TQPM terminal financing. No cross-default to parent debt. Undated chase on confirmed outcome, never pre-position, never average down.
  • July maturity wall: Idesa seeking 1/3 creditor support for an out-of-court restructuring before July; judicial reorganization not ruled out. Decision likely late-June/early-July (est.).
  • Balance sheet gating risk (Q1 2026, reported 2026-05-13): adj net debt US$8.483B, Net Debt/Recurring EBITDA 16.81x, cash US$1.1B, Q1 net loss R$9.9B, ratings CC/CCC- neg. Recurring EBITDA US$192M, +76% QoQ.
  • Sell-side split: JPM Overweight PT $5.50 (2026-05-12, from Neutral); BofA Underperform PT ~$3; consensus Hold ~$3.87 (range $1.50–$6.00, 7 analysts).
  • Not a momentum/cluster setup. Default dormant; any entry requires a confirmed base and reclaim of ~$4 on volume, never average down.
  • Next earnings Q2 2026 ~August (est.); no earnings binary inside 30d. Prior catalyst (2026-06-08 EGM/governance reset) has passed.
  • THEME TAG (authoritative): Braskem = Brazilian petrochemical (PE/PP/PVC) producer, NOT rare-earths/critical-materials. Prior pipeline mis-tagged it 'commodity-materials-rare-earths' and 'critical-materials-rare-earths' both WRONG. Correct tags: petrochem / distressed-credit / EM-Brazil / special-situations.
  • REGIME CHANGE 2026-06-29: distress migrated from Braskem Idesa (75% JV) to the PARENT. Braskem S.A. obtained a tutela cautelar (60-day financial-creditor standstill); Fitch cut to C, S&P to D (default). This supersedes the prior 'Idesa is the tail risk' framing.
  • Liquidity math (June 2026): July debt service ~US$549M, Q3 2026 ~US$878M vs ~US$800M cash; acceleration/early-payment clauses put ~R$54B (~US$10.4B) at risk. Standstill (~60 days from 06-29) expires ~2026-08-28 est.
  • Creditors REJECTED management's initial restructuring proposal and demand 'greater shareholder burden-sharing' (per JPM 2026-06-30) direct equity dilution/impairment risk. Common is a deep option on a benign out-of-court outcome.
  • JPMorgan downgraded to Neutral from Overweight on 2026-06-30, PT cut to R$7.50 from R$15 (Milene Carvalho). Was the last standing bull; consensus now Moderate Sell, avg target ~$3.00.
  • Braskem Idesa still readying US Chapter 11 with a ~US$250M DIP (missed 2029-note interest 2025-11-18, 2032-note interest 2026-02-20); reported imminent early July 2026.
  • Not a narrative-momentum setup: no accelerating theme, no peer cluster, price at 52-week lows (~$2.30 on 2026-07-11, 52wk range $2.25-5.40). Default keep DORMANT; only tradable angle is confirmed event-driven headline never pre-position, never average down.
  • Next earnings Q2 2026 ~mid-August (est.); no earnings binary inside 30 days.
  • Prior invalidation level ($3.00 weekly close) has already been breached refreshed bear-confirm to $2.00 weekly close given the ~$2.30 spot.

Related · shared themes

MRCY

Mercury Systems Inc

Defense-electronics turnaround re-rating inside an accelerating modernization tape: Q3 FY26 (2026-05-06) printed record bookings $348M (+73.7% YoY), 1.48 book-to-bill, record ~$1.6B backlog and +46% EBITDA, with FCF guided positive. But the stock just reversed ~16% off its $128.45 ATH; the ~2026-08-10 Q4/full-year print is the next binary.

MEDIUM

SIMO

Silicon Motion Technology Corporation

NAND-controller toll-booth on the steepest flash shortage in ~15 years: TrendForce H1 2026 contract +>100% cumulative, H2 still rising with no capacity adds. Q1 record +105% YoY, sell-side chasing to $400/$450. Fundamental leg ACCELERATING, but the tape is digesting a 4x into insider selling the 2026-07-29 Q2 print is the next binary.

MEDIUM

XPO

XPO, Inc.

Freight-cycle upturn is the accelerating narrative: LTL volume and contract pricing re-accelerating after a multi-year trucking recession, with SAIA May tonnage +8.4% confirming the cluster. XPO layers operating-ratio self-help (Q1 LTL OR 83.9%, -200bps YoY) on top. The 2026-07-30 Q2 print is the binary that validates or breaks the "comfortably ahead" yield guide.

MEDIUM

IRDM

Iridium Communications Inc

Narrative-momentum thesis is closed: Rocket Lab agreed 2026-06-29 to acquire Iridium for ~$54/share ($27 cash + a calculated ratio of RKLB stock), EV ~$8B. IRDM now trades as merger-arb spread to ~$54 plus embedded RKLB beta not on NTN Direct or spectrum. Morgan Stanley's PT-to-$54 (2026-06-30) confirms the Street marks it to the deal. Upside is capped at terms; the live binary is deal close vs. break on a 6–12 month regulatory clock.

LOW

See also · stocks to watch